Poltreg S.A. (PTG.WA)

PLN 35.0

(4.17%)

Operating Expenses Summary of Poltreg S.A.

  • Poltreg S.A.'s latest annual operating expenses in 2023 was 15.47 Million PLN , up 202.96% from previous year.
  • Poltreg S.A.'s latest quarterly operating expenses in 2024 Q2 was 3.86 Million PLN , up 26.79% from previous quarter.
  • Poltreg S.A. reported a annual operating expenses of 5.1 Million PLN in annual operating expenses 2022, up 18.87% from previous year.
  • Poltreg S.A. reported a annual operating expenses of 4.29 Million PLN in annual operating expenses 2021, up 204.32% from previous year.
  • Poltreg S.A. reported a quarterly operating expenses of 3.86 Million PLN for 2024 Q2, up 26.79% from previous quarter.
  • Poltreg S.A. reported a quarterly operating expenses of 4.2 Million PLN for 2023 Q2, up 92.14% from previous quarter.

Annual Operating Expenses Chart of Poltreg S.A. (2023 - 2018)

Historical Annual Operating Expenses of Poltreg S.A. (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 15.47 Million PLN 202.96%
2022 5.1 Million PLN 18.87%
2021 4.29 Million PLN 204.32%
2020 1.41 Million PLN 56.54%
2019 902 Thousand PLN -21.9%
2018 1.15 Million PLN 0.0%

Peer Operating Expenses Comparison of Poltreg S.A.

Name Operating Expenses Operating Expenses Difference
Bioceltix S.A. 15.38 Million PLN -0.587%
BIOTON S.A. 57.55 Million PLN 73.114%
Captor Therapeutics Spolka Akcyjna 79.91 Million PLN 80.636%
Mabion S.A. 59.52 Million PLN 74.001%
Molecure S.A. 31.73 Million PLN 51.23%
NanoGroup S.A. 7.82 Million PLN -97.722%
Pharmena S.A. -32.76 Million PLN 147.23%
Pure Biologics Spólka Akcyjna 29.14 Million PLN 46.902%
Ryvu Therapeutics S.A. 4.73 Million PLN -226.615%
Synthaverse S.A. 26.35 Million PLN 41.28%
Urteste S.A. 5.96 Million PLN -159.3%